Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.95 USD | +8.11% | +41.77% | -32.62% |
Mar. 27 | Cantor Fitzgerald Trims Price Target on Lucid Diagnostics to $3 From $3.80, Maintains Overweight Rating | MT |
Mar. 26 | Transcript : Lucid Diagnostics Inc., Q4 2023 Earnings Call, Mar 26, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.62% | 47.3M | |
+73.17% | 12.38B | |
-18.08% | 7.99B | |
+16.24% | 7.21B | |
+3.57% | 5.79B | |
+11.77% | 5.35B | |
+29.65% | 4.63B | |
-17.74% | 4.17B | |
-35.34% | 2.44B | |
+2.10% | 2.03B |
- Stock Market
- Equities
- LUCD Stock
- News Lucid Diagnostics Inc.
- Needham Adjusts Price Target on Lucid Diagnostics to $3.10 From $4.25, Maintains Buy Rating